Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: Dose-response comparison to nerve growth factor and brain-derived neurotrophic factor

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 1140-1151

  Williams, Lawrence R ^a   Inouye, Glen ^a   Cummins, Vierka ^a   Pelleymounter, Mary Ann ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOSE RESPONSE; FOREBRAIN; GLIA CELL; MALE; NERVE FIBER TRANSECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AXONS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHOLINE O-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MALE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PARASYMPATHETIC NERVOUS SYSTEM; PROSENCEPHALON; RATS; RATS, WISTAR;

EID: 0030437247     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. ALDERSON, R. F., WIEGAND, S. J., ANDERSON, K. D., CAI, N., CHO, J.-Y., LINDSAY, R. M. AND ALTAR, C. A.: Neurotrophin-4/5 maintains the cholinergic phenotype of axotomized septal neurons. Eur. J. Neurosci., in press, 1996.
2. ALTAR, C. A., CAI, N., LINDSAY, R. M. AND WIEGAND, S. J.: Sprouting of axotomized cholinergic neurons is induced differently by NGF, NT-4/5, and BDNF. Soc. Neurosci. Abstr. 20: 855, 1994a.
3. 125I]NT-3. Eur J. Neurosci. 6: 1389-1405, 1994b.
4. ANDERSON, K. D., ALDERSON, R. F., ALTAR, C. A., DISTEFANO, P. S., CORCORAN, T. L., LINDSAY, R. M. AND WIEGAND, S. J.: The differential distribution of exogenous BDNF, NGF and NT-3 in the brain corresponds to the relative distribution of high-affinity and low-affinity neurotrophin receptors. J. Comp. Neurol. 357: 296-317, 1995.
5. APPEL, S. H.: A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism and Alzheimer disease. Ann. Neurol. 10: 499-505, 1981.
6. BATCHELOR, P. E., ARMSTRONG, D. M., BLAKER, S. N. AND GAGE, F. H.: Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: Response to fimbria-fornix transaction. J. Comp. Neurol. 284: 187-204, 1989.
7. BECK, K. D., VALVERDE, J , ALEXI, T., POULSEN, K., MOFFAT, B., VANDLEN, R. A , ROSENTHAL, A. AND HEFTI, F.: Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373: 339-341, 1995.
8. BOTHWELL, M.: Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci. 18: 223-253, 1995.
9. BUTCHER, L. L. AND WOOLF, N. J.: Neurotrophic agents exacerbate the pathologic cascade of Alzheimer's disease. Neurobiol. Aging 10: 557-570, 1989.
10. CHAO, M. V. AND HEMPSTEAD, B. L : p75 and Trk: A two-receptor system. TINS 18: 321-326, 1995.
11. COLLINS, F. AND LILE, J. D.: The role of dihydropyridine-sensitive voltage-gated calcium channels in potassium-mediated neuronal survival. Brain Res. 502: 99-108, 1989.
12. DAITZ, H. M. AND POWELL, T. P. S.: Studies of the connexions of the fornix system. J. Neurol. Neurosurg. Psychiat. 17: 75-82, 1954.
13. DELLA SETA, D., DE ACETIS, L., ALOE, L. AND ALLEVA, E.: NGF effects on hot plate behaviors in mice. Pharmacol. 49: 701-705, 1994.
14. EMMETT, C. J., ASWANI, S. P., STEWART, G. R., FAIRCHILD, D AND JOHNSON, R. M.: Dose-response comparison of recombinant human nerve growth factor and recombinant human fibroblast growth factor in the fimbria fornix model of acute cholinergic degeneration. Brain Res. 673: 199-207, 1995.
15. FISCHER, W., SIREVAAG, A., WIEGAND, S. J., LINDSAY, R. M. AND BJÖRKLUND, A.: Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 91: 8607-8611, 1994
16. GAGE, F. H., ARMSTRONG, D. M., WILLIAMS, L. R AND VARON, S.: Morphological response of axotomized septal neurons to nerve growth factor. J. Comp. Neurol. 269: 147-155, 1988.
17. GAGE, F. H., BJÖRKLUND, A. AND STENEVI, U.: Reinnervation of the partially deafferented hippocampus by compensatory collateral sprouting from spared cholinergic and noradrenergic afferents. Brain Res 268: 27-37, 1983.
18. GAGE, F. H., WICTORIN, K., FISCHER, W., WILLIAMS, L. R., VARON, S. AND BJÖRKLUND, A : Retrograde cell changes in medial septum and diagonal band following fimbriafornix transection: Quantitative temporal analysis. Neuroscience 19: 241-255, 1986.
19. GASH, D. M., ZHANG, Z , CASS, W. A., OVADIA, A., MARTIN, D., RUSSELL, D., COLLINS, F., HOFFER, B. J. AND GERHARDT, G. A.: Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J. Comp. Neurol. 363: 345-358, 1995.
20. HAGG, T., FASS-HOLMES, B., VAHLSING, H. L , MANTHORPE, M., CONNER, J. M. AND VARON, S : Nerve growth factor (NGF) reverses axotomy-induced decreases in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons. Brain Res. 505: 29-38, 1989a.
21. HAGG, T , HAGG, F., VAHLSING, H. L., MANTHORPE, M. AND VARON, S : Nerve growth factor effects on cholinergic neurons of neostriatum and nucleus accumbens in the adult rat. Neuroscience 30: 95-103, 1989b.
22. HAGG, T., MANTHORPE, M., VAHLSING, H. L. AND VARON, S.: Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage. Exp. Neurol. 101: 303-312, 1988.
23. HAGG, T. AND VARON, S.: Neurotropism of nerve growth factor for adult rat septal cholinergic axons in vivo. Exp. Neurol. 119: 37-45, 1993.
24. HEPTI, F., DRAVID, A. AND HARTIKKA, J.: Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 293: 305-311, 1984.
25. HEFTI, F : Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6: 2155-2162, 1986.
26. HEFTI, F.: Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25: 1418-1435, 1994.
27. HEFTI, F. AND LAPCHAK, P. A.: Pharmacology of NGF in the brain. Adv. Pharmacol. 24: 239-273, 1993.
28. HEFTI, F. AND WEINER, W. J.: Nerve growth factor and Alzheimer's disease. Ann. Neurol. 20: 275-281, 1986.
29. HENDERSON, C. E., PHILLIPS, H. S., POLLOCK, R A., DAVIES, A. M., LEMEULLE, C., ARMANINI, M., SIMPSON, L. C., MOFFET, B., VANDLEN, E. A , KOLIATSOS, V. E. AND ROSENTHAL, A.: GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266: 1062-1064, 1994.
30. HOFFER, B. J., HOFFMAN, A., BOWENKAMP, K., HUETTL, P., HUDSON, J , MARTIN, D., LIN, L.-F. H. AND GERHARDT, G. A.: Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182: 107-111, 1994.
31. trk mRNA marks NGF-responsive forebrain neurons: Evidence that trk gene expression is induced by NGF. Neuron 9: 465-478, 1992.
32. HUDSON, J., GRANHOLM, A.-C., GERHARDT, G. A., HENRY, M. A., HOFFMAN, A., BIDDLE, P., LEELA, N. S., MACKERLOVA, L., LILE, J. D., COLLINS, F. AND HOFFER, B. J.: Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36: 425-432, 1995.
33. KEARNS, C. M. AND GASH, D. M.: GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672: 104-111, 1995.
34. KISS, J., MCGOVERN, J. AND PATEL, A. J.: Immunohistochemical localization of cells containing nerve growth factor receptors in the different regions of the adult rat forebrain. Neuroscience 27: 731-748, 1988.
35. KNÜSEL, B., BECK, K. D., WINSLOW, J. W., ROSENTHAL, A., BURTON, L. E., WIDMER, H. R., NIKOLICS, K. AND HEFTI, F.: Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12: 4391-4402, 1992.
36. KOLIATSOS, V. E., CLATTERBUCK, R. E., NAUTA, H. J. W., KNUSEL, B., BURTON, L. E., HEFTI, F., MOBLEY, W. C. AND PRICE, D. L.: Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann. Neurol. 30: 831-840, 1991.
37. KOLIATSOS, V. E., PRICE, D. L., GOURAS, G. K., CAYOUETTE, M. H., BURTON, L. E. AND WINSLOW, J. W.: Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons. J. Comp. Neurol. 343: 247-262, 1994.
38. KORDOWER, J. H., BARTUS, R. T., BOTHWELL, M., SCHATTEMAN, G. AND GASH, D. M.: Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): Distribution, morphology, and colocalization with cholinergic enzymes. J. Comp. Neurol. 277: 465-486, 1988.
39. + toxicity. EMBO J. 14: 736-742, 1995.
40. LAPCHAK, P. A.: Nerve growth factor pharmacology: Application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp. Neurol. 124: 16-20, 1993.
41. LAPCHAK, P. A. AND ARAUJO, D. M.: NGF suppression of weight gain in adult female rats correlates with decreased hypothalamic cholecystokinin levels. Brain Res. 655: 12-16, 1994.
42. LAPCHAK, P. A., ARAUJO, D. M. AND HEFTI, F.: Neurotrophins in the central nervous system. Rev. Neurosci. 3: 1-10, 1993.
43. LAPCHAK, P. A. AND HEFTI, F.: BDNF and NGF treatment in lesioned rats: effects on cholinergic function and weight gain. Neuroreport 3: 405-408, 1992.
44. LEVI-MONTALCINI, R.: Developmental neurobiology and the natural history of nerve growth factor. Annu. Rev. Neurosci. 5: 341-362, 1982.
45. LEWIN, G. R. AND MENDELL, L. M.: Nerve growth factor and nociception. Trends Neurosci. 16: 353-359, 1993.
46. LI, Y., HOLTZMAN, D. M., KROMER, L F., KAPLAN, D. R., CHUA-COUZENS, J., CLARY, D. O., KNÜSEL, B. AND MOBLEY, W. C.: Regulation of TrkA and ChAT expression in developing rat basal forebrain: Evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J. Neurosci. 15: 2888-2905, 1995.
47. LIN, L.-F. H., DOHERTY, D. H , LILE, J. D., BEKTESH, S. AND COLLINS, F.: GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132, 1993
48. MILLER, G., MARTIN, D. AND CULLEN, T : Central administration of rhGDNF causes augmentation of dopaminergic activity in vivo. Soc. Neurosci. Abstr. 20: 1300, 1994.
49. MOISES, H. C , WOMBLE, M. D., WASHBURN, M. S. AND WILLIAMS, L. R.: Nerve growth factor fascilitates cholinergic neurotransmission between nucleus basalis and the amygdala in rat: An electrophysiological analysis. J. Neurosci. 15: 8131-8142, 1995.
50. MORSE, J. K., WIEGAND, S. J., ANDERSON, K., YOU, Y., CAI, N., CARNAHAN, J., MILLER, J., DISTEFANO, P. S., ALTAR, C. A., LINDSAY, R. M. AND ALDERSON, R. F.: Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J. Neurosci. 13: 4146-4156, 1993
51. NAUMANN, T., KERMER, P. AND FROTSCHER, M.: Fine structure of rat septohippocampal neurons. III. Recovery of choline acetyltransferase immunoreactivity after fimbria-fornix transection. J. Comp. Neurol. 350: 161-170, 1994.
52. NAUMANN, T., PETERSON, G. M. AND FROTSCHER, M.: Fine structure of rat septohippocampal neurons: II. A time course analysis following axotomy. J. Comp Neurol. 325: 219-242, 1992.
53. OLSON, L.: Neurotrophins in neurodegenerative disease: Theoretical issues and clinical trials. Neurochem. Intl. 25: 1-3, 1994.
54. 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient. J. Neural Transm. 4: 79-95, 1992.
55. OPPENHEIM, R. W., HOUENOU, L. J., JOHNSON, J. E., LIN, L.-F. H., LI, L., LO, A. C , NEWSOME, A. L., PREVETTE, D. M. AND WANG, S.: Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373: 344-346, 1996.
56. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaric Coordinates. Academic Press, Inc., San Diego, 1986
57. PEARSON, R. C. A., SOFRONIEW, M. V., CUELLO, A. C., POWELL, T. P. S., ECKENSTEIN, F., ESIRI, M. M. AND WILCOCK, G. K.: Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res. 289: 375-379, 1983.
58. PELLEYMOUNTER, M. A., CULLEN, M. J. AND WELLMAN, C. L.: Characteristics of BDNF-induced weight loss. Exp. Neurol. 131: 229-238, 1995.
59. PETERSON, G. M., NAUMANN, T. AND FROTSCHER, M.: Identified septohippocampal neurons survive axotomy: A fine-structural analysis in the rat. Neurosci. Lett. 138: 81-85, 1992.
60. PETTY, B. G., CORNBLATH, D. R., ADORNATO, B. T., CHAUDHRY, V., FLEXNER, C., WACHSMAN, M., SINICROPI, D., BURTON, L. E. AND PEROUTKA, S. J.: The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann. Neurol. 36: 244-246, 1994.
61. PHELPS, C. H., GAGE, F. H., GROWDON, J. H., HEFTI, F., HARBAUGH, R., JOHNSTON, M. V., KHACHATURIAN, Z. S., MOBLEY, W. C., PRICE, D. L., RASKIND, M., SIMPKINS, J., THAL, L. J. AND WOODCOCK, J.: Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol. Aging 10: 205-207, 1989.
62. POULSEN, K. T., ARMANINI, M. P., KLEIN, R. D., HYNES, M. A., PHILLIPS, H. S. AND ROSENTHAL, A.: TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13: 1245-1252, 1994.
63. RYLETT, R. J., GODDARD, S., SCHMIDT, B. M. AND WILLIAMS, L. R.: Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats. J. Neurosci. 13: 3956-3963, 1993.
64. RYLETT, R. J. AND WILLIAMS, L. R.: Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci. 17: 486-490, 1994.
65. SCHRIER, C. AND SHUSTER, M.: A simplified radiochemical assay for choline acetyltransferase. J. Neurochem. 14: 977-985, 1967
66. SMOLEN, A. J.: Image analytic techniques for quantification of immunohistochemical staining in the nervous system. In Methods in Neurosciences, ed. by P. M. Conn, pp. 208-229, Academic Press, Inc. San Diego, CA, 1990.
67. SOFRONIEW, M. V., COOPER, J. D., SVENDSEN, C. N., CROSSMAN, P., IP, N. Y., LINDSAY, R. M., ZAFRA, F. AND LINDHOLM, D.: Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3. J. Neurosci. 13: 5263-5276, 1993.
68. SPRINGER, J. E., KOH, S., TAYRIEN, M. W. AND LOY, R.: Basal forebrain magnocellular neurons stain for nerve growth factor receptor: Correlation with cholinergic cell bodies and effects of axotomy. J. Neurosci. Res. 17: 111-118. 1987.
69. STEININGER, T. L., WAINER, B. H., KLEIN, R., BARBACID, M. AND PALFREY, H. C.: High-affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain. Brain Res. 612: 330-335, 1993.
70. STROMBERG, I., BJÖRKLUND, A., JOHANSSON, M., TOMAC, A., COLLINS, F., OLSON, L , HOFFER, B. AND HUMPEL, C.: Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124: 401-412, 1995.
71. THOENEN, H.: The changing scene of neurotrophic factors. Trends Neurosci. 14: 165-170, 1991.
72. TOMAC, A., LINDQVIST, E., LIN, L.-F. H., ÖGREN, S. O., YOUNG, D., HOFFER, B. J. AND OLSON, L.: Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335-339, 1995.
73. TUSZYNSKI, M. H., ARMSTRONG, D. M. AND GAGE, F. H.: Basal forebrain cell loss following fimbria/fornix transection. Brain Res. 508: 241-248, 1990.
74. VAHLSING, H. L., HAGG, F., SPENCER, M., CONNER, J. M., MANTHORPE, M. AND VARON, S.: Dose-dependent responses to nerve growth factor by adult rat cholinergic medial septum and neostriatum neurons. Brain Res. 552: 320-329, 1991.
75. VARON, S., MANTHORPE, M. AND WILLIAMS, L. R.: Neuronotrophic and neurite promoting factors and their clinical potentials. Dev. Neurosci. 6: 73-100, 1984.
76. VENERO, J. L. AND HEFTI, F.: TrkA NGF receptor expression by non-cholinergic thalamic neurons. Neuroreport 4: 959-962, 1993.
77. VENERO, J. L., KNUSEL, B., BECK, K. D. AND HEFTI, F.: Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: Effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration. Neuroscience 59: 797-815, 1994.
78. WIDMER, H. R., KNÜSEL, B. AND HEFTI, F.: BDNF protection of basal forebrain cholinergic neurons after axotomy: Complete protection of p75NGFR-positive cells. Neuroreport 4: 363-366, 1993.
79. WILLIAMS, L. R., VARON, S., PETERSON, G. M., WICTORIN, K., FISCHER, W., BJORKLUND, A. AND GAGE, F. H.: Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transaction. Proc. Natl. Acad. Sci. USA 83: 9231-9235, 1986.
80. WILLIAMS, L. R., JODELIS, K. S. AND DONALD, M. R.: Axotomy-dependent stimulation of choline acetyltransferase by exogenous mouse nerve growth factor in rat basal forebrain. Brain Res. 498: 243-256, 1989.
81. WILLIAMS, L. R : Exogenous nerve growth factor stimulates choline acetyltransferase activity in aging Fischer 344 male rats. Neurobiol. Aging 12: 39-46, 1991a.
82. WILLIAMS, L. R.: Hypophagia is induced by introcerebroventricular administration of nerve growth factor. Exp. Neurol. 113: 31-37, 1991b.
83. WILLIAMS, L. R. AND OOSTVEEN, J. A.: Sensitivity of Fischer 344 X Brown Norway hybrid rats to exogenous NGF: Weight loss correlates with stimulation of striatal choline acetyltransferase. Neurosci. Lett. 147: 136-138, 1992.
84. WOOLF, N. J., GOULD, E. AND BUTCHER, L. L.: Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon. Neuroscience 30: 143-152, 1989.
85. WOOLF, C. J., SAFIEH GARABEDIAN, B., MA, Q. P., CRILLY, P. AND WINTER, J.: Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62: 327-331, 1994.
86. YAN, Q. AND MATHESON, C. R : Retrograde transport study of glial cell line-derived neurotrophic factor (GDNF) in adult rat nervous system. Soc. Neurosci. Abstr. 21: 1301, 1995.
87. YAN, Q., MATHESON, C. AND LOPEZ, O. T.: In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373: 341-344, 1995.
88. YAN, Q., MATHESON, C., SUN, J , RADEKE, M. J., FEINSTEIN, S. C. AND MILLER, J. A.: Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with Trk receptor expression. Exp Neurol. 127: 23-36, 1994.
89. ZURN, A. D., BAETGE, E. E., HAMMANG, J P., TAN, S. A. AND AEBISCHER, P.: Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones. Neuroreport 6: 113-118, 1994.